Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Prism Industries is a private Indian pharmaceutical manufacturing company focused on active pharmaceutical ingredients, bulk drugs, pharmaceutical intermediates, and selected specialty chemicals. The company operates as a commercial-stage supplier rather than a drug developer, with a portfolio that includes antimalarial APIs, antispasmodics, nicotine-related ingredients, and other small-molecule products for pharmaceutical manufacturing. Prism emphasizes GMP-aligned quality systems, in-house quality control, regulatory support, custom synthesis, and private-label services for customers in domestic and export markets. Its business appears centered on supplying high-purity raw materials and intermediates to pharma customers across Asia, Europe, Africa, and the Americas.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Prism Industries.